Dynex Capital, Inc. (DX) — closed signal from November 5, 2025
Target reached Published before the outcome was known, scored automatically when the window closed on February 3, 2026.
Predicted vs. what happened
What happened
Reached its target in 72 days.
The thesis — published November 5, 2025
Dynex is a mortgage investment company seen as solid, with strong score 85 on core health and 97 on market mood. As interest rates cool, both analyst views call for a steady, short-term move. Buying pressure looks steady, the recent average price is rising, and price swings have been small. New portfolio growth updates and a New York office add capacity. We expect steady income plus modest gains over about three months to balance tech risk.
Primary drivers
- Strong company health (85) and very positive market mood (97) support gains.
- Recent average price is rising, and day-to-day price moves have been mild.
- Updates show portfolio growth; new New York office should boost capabilities.
- Plan aims for income plus steady gains over about three months.
How it played out
DX: target reached in 72 days
Lyra published DX at $13.08 on 2025-11-05, with a short-term window ending 2026-02-03. The thesis expected 12% growth. It pointed to company health of 85, market mood of 97, a rising recent average price, mild day-to-day moves, portfolio growth updates, and a New York office adding capacity.
Inside the window, DX reached a peak of $14.93 on 2026-01-28. That was above the $14.29 target, with a peak gain of 14.1%. The target was reached in 72 days. DX ended the window at $14.04. The thesis played out.
Prices are shown split- and dividend-adjusted, matching what public charts show today.
Share this receipt
A scored call, published before the outcome was known. Paste the link anywhere — it unfurls as the card above.
Read the next call before it closes.
This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.